# FDA Inspection 1291202 - American National Red Cross - February 11, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/13e9f68e-8443-44fb-9931-11736916f953
Source feed: FDA_Inspections

> FDA Inspection 1291202 for American National Red Cross on February 11, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291202
- Company Name: American National Red Cross
- Inspection Date: 2026-02-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1221160 - 2023-10-24](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/3785b86c-2584-4749-a5a1-33244af4b1d6)
- [FDA Inspection 1177541 - 2022-08-09](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/da580740-7513-4d0c-a0e7-ebfad2331f86)

Company: https://www.globalkeysolutions.net/companies/american-national-red-cross/0489c541-f853-47f9-a608-8b6bb2ab08de

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d